Development and Evaluation of an Optimal Machine Learning Model for Predicting Nutritional Risk in Nasopharyngeal Carcinoma Patients: A Cross-Sectional Study

Nutrition and Cancer · Published 2025-11-24 · DOI 10.1080/01635581.2025.2591494

Authors being retrieved — see the publisher record. https://doi.org/10.1080/01635581.2025.2591494

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2025

Related articles

• Dietary Protein Intake and Low Muscle Strength in Women with Breast Cancer: An Association Study · Nutrition and Cancer · 2026 · Same journal
• Methodological Considerations in “The Nutritional Impact of Childhood Cancer: Insights from a Feasibility Cohort Study” · Nutrition and Cancer · 2026 · Same journal
• Evaluation of the Relationship Between Sarcopenia, Nutritional Status, and Frailty in Older Patients with Cancer · Nutrition and Cancer · 2025 · Same journal
• Development of a Machine Learning-Based Nutrition-Related Surgical Risk Assessment Model for Older Patients with Gastrointestinal Malignancies · Nutrition and Cancer · 2025 · Same journal
• Response to the Letter Concerning “Revisiting the Impact of Obesity on Cancer-Specific Survival in Rectal Cancer—Clinical and Translational Implications” · Nutrition and Cancer · 2025 · Same journal
• A Scoping Review of Ultra-Processed Food Consumption and Cancer Risk: Implications for Public Health, Registered Dietitian Nutritionists and Other Healthcare Professionals · Nutrition and Cancer · 2025 · Same journal
• Inflammatory Potential of Diet Scores and the Risk of Endometrial Cancer: A Case-Control Study · Nutrition and Cancer · 2025 · Same journal
• Fatty Acid Intake and Bladder Cancer Risk: A Multicenter Case-Control Study in Iran · Nutrition and Cancer · 2026 · Same journal
• Considering Body Mass Index for Skin Cancer Prevention Using Oral Nicotinamide · Nutrition and Cancer · 2026 · Same journal
• The Impact of Whole-Course Immunonutrition Management on Patients With Stage III and IV Nasopharyngeal Carcinoma Undergoing Concurrent Chemoradiotherapy: A Randomized Controlled Trial · Nutrition and Cancer · 2025 · Same journal